Congratulations to Dr. Chen Ching for receiving the scholarship from the Institute of Pharmacology for her dissertation.

Under the guidance of Professor Chang Ting-Ting, Dr. Chen Ching has focused on the study of cardiovascular complications in diabetes mellitus and has published her findings in international journals, earning her a scholarship from the Institute of Pharmacology in the Spring semester of 2024. Her research investigated the role of CXCL5 in diabetic vascular disease and revealed the potential of CXCL5 inhibition to enhance neovascularization and wound healing. The study found that CXCL5 levels were elevated in diabetic patients and that CXCL5, through the CXCR2 receptor, regulated pro-inflammatory factors, suppressing the angiogenesis-related molecules VEGF and SDF-1. However, using a CXCL5-neutralizing antibody significantly improved blood flow recovery, increased neovascularization, and promoted wound healing. These findings suggested that CXCL5 could become a novel therapeutic target for diabetic vascular complications. In addition, Dr. Chen Ching has also written a review article on CXCL5 in cardiovascular diseases, diabetes mellitus, and kidney disease, exploring the key role of CXCL5 in these conditions. This fills a gap in the relevant fields and provides new insights into potential therapeutic targets for these diseases. Congratulations to Dr. Chen Ching on obtaining her doctoral degree in November 2024.